 | | | | Moderna Inc said on Tuesday it has completed its submission to the U.S. Food and Drug Administration for the emergency use authorization of its COVID-19 booster shot tailored against the BA.4 and BA.5 subvariants of Omicron. | | | | | | The United Nations-backed COVAX vaccine program has offered Mexico 10 million doses of Pfizer /BioNTech COVID-19 shots for children after the country's president vowed to complain to the U.N. over delays, a senior Mexican official said on Tuesday. | | | | | | The European Medicines Agency (EMA) will hold an extraordinary meeting on Sept. 1 to discuss applications from Moderna and Pfizer for vaccine boosters modified to target the Omicron variant, the regulator said on Tuesday. | | | | | | AstraZeneca's Chief Executive Pascal Soriot warned on Tuesday new U.S. legislation capping drug prices would reduce the ability of companies to recoup their investment on developing new drugs and hurt innovation. | | | | | | The Biden administration will extend through year end waivers that make it easier for low-income families to access baby formula through a government program, the U.S. Department of Agriculture (USDA) plans to announce on Tuesday. | | | | | | AstraZeneca may not stay in the vaccine business in the long run, its CEO told Reuters on Tuesday, showing how quickly fortunes have changed for the drugmaker that produced one of the first COVID-19 shots but has since lost out to rivals. | | | | | | Pfizer Inc and BioNTech's vaccine was 73.2% effective in preventing COVID-19 among children aged 6 months through 4 years, new data from the companies showed on Tuesday, two months after the U.S. rollout of the shots began for that age group. | | | | | | Medtronic Plc on Tuesday stuck to its 2023 earnings forecast in the face of supply chain shortages and rising costs, raising investor doubts in the device maker's ability to achieve its target at a time when its smaller rivals cut their outlooks. | | | | | | The British scientists behind one of the major therapeutic COVID-19 trials have turned their focus to treatments for monkeypox, a viral disease that has been labeled a global health emergency by the World Health Organization (WHO). | | | | | | A reliance on vaccines in short supply and questions over their best use are hampering efforts to curb the global spread of monkeypox which has hit dozens of countries for the first time, health officials say. | | | | | |
